Ingeborg Bajema Selected Research

Kidney Diseases (Kidney Disease)

1/2022	Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study.
1/2022	Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingeborg Bajema Research Topics

Disease

4	Proteinuria 03/2024 - 11/2012
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 06/2023 - 09/2014
3	Lupus Nephritis 11/2023 - 11/2012
3	Rheumatic Diseases (Rheumatism) 01/2020 - 11/2012
2	Infections 11/2023 - 07/2011
2	Renal Insufficiency (Renal Failure) 01/2023 - 03/2006
2	Kidney Diseases (Kidney Disease) 01/2022 - 01/2022
2	Vasculitis (Vasculitides) 01/2017 - 07/2011
1	Glomerulonephritis 12/2023
1	Fibrosis (Cirrhosis) 12/2023
1	Atrophy 12/2023
1	Hematuria 01/2023
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022
1	Aneuploidy (Aneuploid) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2019
1	Body Weight (Weight, Body) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2017
1	Microscopic Polyangiitis 01/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 04/2009
1	Insulin Resistance 04/2009
1	Jaundice (Icterus) 03/2006
1	Toxemia 03/2006

Drug/Important Bio-Agent (IBA)

5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2023 - 07/2011
3	CreatinineIBA 03/2024 - 03/2006
3	GlucocorticoidsIBA 11/2023 - 11/2012
3	Edetic Acid (EDTA)FDA Link 01/2020 - 11/2012
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2023
1	BI 655064IBA 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	EndopeptidasesIBA 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	AntibodiesIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Calcineurin InhibitorsIBA 01/2020
1	AldosteroneIBA 01/2020
1	AngiotensinsIBA 01/2020
1	ReninIBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Immunoglobulin A (IgA)IBA 10/2019
1	Antiphospholipid AntibodiesIBA 01/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Azathioprine (Imuran)FDA LinkGeneric 09/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2014
1	NucleotidesIBA 04/2009
1	Glucose (Dextrose)FDA LinkGeneric 04/2009
1	BilirubinIBA 03/2006
1	Bile Acids and Salts (Bile Acids)IBA 03/2006
1	Serum AlbuminIBA 03/2006

Therapy/Procedure

4	Therapeutics 03/2024 - 09/2014
3	Remission Induction 01/2023 - 09/2014
1	Aftercare (After-Treatment) 01/2023